- Onkamo, P., Vaananen, S., Karvonen, M. and Tuomilehto, J. (1999) "Worldwide increase in incidence of type 1 diabetes-the analysis of the data on published incidence trends", Diabetologia 42, 1395-1403.
- Diabetes Prevention Trial - Type 1 Diabetes Study Group (2002) "Effects of insulin in relatives of patients with type 1 diabetes mellitus", N. Engl. J. Med. 346, 1685-1691.
- Knip, M., Douek, I.F., Moore, W.P., Gillmor, H.A., McLean, A.E., Bingley, P.J., et al. (2000) "Safety of high dose nicotinamide: a review", Diabetologia 43, 1337-1345.
- Atkinson, M.A. and Eisenbarth, O.S. (2001) "Type 1 diabetes: new perspectives on disease pathogenesis and treatment", Lancet 358, 221-229.
- Eisenbarth, G.S. (1986) "Type 1 diabetes mellitus: a chronic autoimmune disease", N. Engl J. Med. 314, 1360-1368.
- Sreenan, S., Pick, AJ., Levisetti, M., Baldwin, A.C., Pugh, W. and Polonsky, K.S. (1999) "Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse", Diabetes 48, 989-996.
- Shimada, A., Charlton, B., Taylor-Edwards, C. and Fathman, C.G. (1996) "ß-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice", Diabetes 45, 1063-1067.
- Gazda, L.S., Charlton, B. and Lafferty, K.J. (1997) "Diabetes results from a late change in the autoimmune response of NOD mice" J. Autoimmun. 10, 261-270.
- Verge, CE, Gianani, R., Kawasaki, E., Yu, L., Pietropaolo, M., Jackson, R.A., et al (1996) "Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies", Diabetes 45, 926-933.
- Lernmark, A. (2001) "Series introduction: autoimmune diseases: are markers ready for prediction?", J. Clin. Investig. 108, 1091-1096.
- Peterson, J.D., Herzenberg, L.A., Vasquez, K. and Waltenbaugh, C. (1998) "Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns", Proc. Nail Acad. Sci. USA 95, 3071-3076.
- Dobashi, K., Aihara, M., Araki, T, Shimizu, Y, Utsugi, M., lizuka, K., et al. (2001) "Regulation of LPS induced IL-12 production by IFN-? and IL-4 through intracellular glutathione status in human alveolar macrophages", Clin. Exp. Immunol 124, 290-296.
- Murata, Y., Shimamura, T. and Hamuro, J. (2002) "The polarization of Th1/Th2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production", Int. Immunol 14, 201-212.
- Kenny, A.J. (1955) "Extractable glucagon of human pancreas", J Clin. Endocrinol Metab. 15, 1089-1105.
- Scott, R.B., Collins, J.M., Matin, S., White, F. and Swerdlow, P.S. (1990) "Simultaneous measurement of neutrophil, lymphocyte, and monocyte glutathione by flow cytometry", J. Clin. Lab. Anal. 4, 324-327.
- Watanabe, K., Tanaka, R., Nishimura.T., Kumagai, Y., Miyazaki, J., Yamamura, K., et al. (1991) "I-E restricted monoclonal expansion of B lymphocytes in the thymus of NOD mouse", Int. Immunol 3, 839-842.
- Rohane, P.W., Shimada, A., Kim, D.T., Edwards, C.T., Charlton, B., Shultz, L.D., et al (1995) "Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice", Diabetes 44, 550-554.
- Shimada, A., Rohane, P., Fathman, C.G. and Charlton, B. (1996) "Pathogenic and protective roles of CD45RBlow CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse", Diabetes 45, 71-78.
- Mosmann, T.R. and Coffman, R.L. (1989) "Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties", Ann. Rev Immunol 7, 145-173.
- Ryu, S., Kodama, S., Ryu, K., Schoenfeld, D.A. and Faustman, D.L. (2001 ) "Reversal of established autoimmune diabetes by restoration of endogenous beta cell function", J. Clin. Investig. 108, 63-72.
- Palmer, J.P. (2001) "Immunomodulatory therapy of human type 1 diabetes: lessons from the mouse", J. Clin. Investig. 108, 31-33.
- Yu, L., Robles, D.T., Abiru, N., et ai (2000) "Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early detemination of subsequent diabetes", Proc. Natl Acad. Sci USA 97, 1701-1706.
- Abiru, N., Yu, L., Miao, D., Kaur, P., Rewers, M., Kelemen, K.,et al (2001) 'Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains", J. Autoimmun. 17, 1 -6.
- Abiru, N., Maniatis, A.K., Yu, L., Miao, D., Moriyama, H., Wegmann, D., et ai (2001) "Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice", Diabetes SO, 1274-1281.
- Mills, C.D., Kincaid, K., Alt, J.M., Heilman, M.J. and Hill, A.M. (2000) "M-1/M-2 macrophages and the Th1/Th2 paradigm", J. Immunol 164, 6166-6173.
- Droge, W., Schulze-Osthoff, K., Mihm, S., Galter, D., Schenk, H., Eck, H.P., et al (1994) "Function of glutathione and glutathione disulfide in immunology and immunopathology", FASEB J. 8, 1131-1138.
- Roederer, M., Staal, F.I., Osada, H., Herzenberg, L.A. and Herzenberg, L.A. (1991) "CD4 and CDS T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses", Int. Immunol 3, 933-937.
- Herzenberg, L.A., De Rosa, S.C., Dubs, I.G., Roederer, M., Anderson, MT., EIa, S.W., et al. (1997) "Glutathione deficiency is associated with impaired survival in HIV disease", Proc. Nail Acad. Sci USA 94, 1967-1972.
- Short, S., Merkel, B.J., Caffrey, R. and McCoy, K.L. (1996) "Defective antigen processing correlates with a low level of intracellular glutathione", Eur. J. Immunol 26, 3015-3020.
- Gmunder, H., Eck, H.P., Benninghoff, B., Roth, S. and Droge, W. (1990) "Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine", Cell Immunol 129, 32-46.
- Piganelli, I.D., Martin, T. and Haskins, K. (1998) "Splenic macrophages from the NOD mouse are defective in the ability to present antigen", Diabetes 47, 1212-1218.
- Murata, Y. and Hamuro, J. (2000) "Pathophysiology of type 1 diabetes and oxidative and reductive form macrophages", Proc. Jpn Soc. Immunol 30, 231.
Assessment of β Cell Mass and Oxidative Peritoneal Exudate Cells in Murine Type 1 Diabetes using Adoptive Transfer System
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.